Your browser doesn't support javascript.
loading
Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2.
Park, Kyong-Su; Svennerholm, Kristina; Crescitelli, Rossella; Lässer, Cecilia; Gribonika, Inta; Andersson, Mickael; Boström, Jonas; Alalam, Hanna; Harandi, Ali M; Farewell, Anne; Lötvall, Jan.
Afiliação
  • Park KS; Krefting Research Centre, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. kyong-su.park@gu.se.
  • Svennerholm K; Department of Anesthesiology and Intensive Care Medicine, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Crescitelli R; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Lässer C; Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
  • Gribonika I; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Andersson M; Krefting Research Centre, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Boström J; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
  • Alalam H; Department of Chemistry and Molecular Biology, Centre for Antibiotic Resistance, University of Gothenburg, Gothenburg, Sweden.
  • Harandi AM; Department of Chemistry and Molecular Biology, Centre for Antibiotic Resistance, University of Gothenburg, Gothenburg, Sweden.
  • Farewell A; Department of Chemistry and Molecular Biology, Centre for Antibiotic Resistance, University of Gothenburg, Gothenburg, Sweden.
  • Lötvall J; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
J Nanobiotechnology ; 21(1): 156, 2023 May 19.
Article em En | MEDLINE | ID: mdl-37208676

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Bacteriemia / Infecções por Escherichia coli / COVID-19 Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Bacteriemia / Infecções por Escherichia coli / COVID-19 Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia